Evolent Health (EVH) Change in Accured Expenses (2015 - 2026)

Evolent Health has reported Change in Accured Expenses for 12 years, with the latest figure at -$1.4 million in Q2 2026.

• On a quarterly basis, Change in Accured Expenses fell 110.51% year-over-year to -$1.4 million in Q2 2026; TTM through Jun 2026 was $785000.0, a 115.7% increase from a year earlier, with the FY2025 full-year figure at $17.3 million, up 171.36% from the prior year.
• Change in Accured Expenses was -$1.4 million for Q2 2026 at Evolent Health, up from -$21.0 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $48.2 million in Q3 2023, with the low at -$32.4 million in Q1 2022.
• Average Change in Accured Expenses over 5 years is -$1.9 million, with a median of -$1.1 million recorded in 2022.
• The largest YoY upside for Change in Accured Expenses was 9558.95% in 2025 against a maximum downside of 854.81% in 2025.
• Over 5 years, Change in Accured Expenses stood at -$888000.0 in 2022, then plunged by 337.39% to -$3.9 million in 2023, then jumped by 114.98% to $582000.0 in 2024, then tumbled by 854.81% to -$4.4 million in 2025, then soared by 68.86% to -$1.4 million in 2026.
• The last three Change in Accured Expenses figures came in at -$1.4 million (Q2 2026), -$21.0 million (Q1 2026), and -$4.4 million (Q4 2025), per Business Quant data.